Basic Science News at Duke School of Medicine

Scientists at Duke University School of Medicine have long probed the mysteries of RNA, with an eye to harnessing its power for new and better therapies for cancer, diabetes, heart disease and more.

Dean’s Award for Research Excellence recognizes basic science achievements of PhD candidates and their impact beyond the lab.

A common powerful mutation found in melanoma can push heart muscle cells to multiply in laboratory models of heart tissue.

A perplexing problem for people with recurring urinary tract infections (UTIs) is persistent pain, even after antibiotics have successfully cleared the bacteria. Now Duke Health researchers have identified the likely cause - an overgrowth of nerve cells in the bladder.

Duke University, in collaboration with the University of North Carolina-Chapel Hill and ​​​NC​​ State University, has received a three-year, $3 million grant from the Chan​ ​Zuckerberg Initiative (CZI) to map and manipulate the unseen complexities of biological networks, with a focus on kinases.  Their work on kinases, which is a class of proteins, will help researchers better understand cellular organization, nervous system function, and neurological diseases affecting the brain. The living kinome is the complete set of protein kinases encoded in the genome.  

Duke School of Medicine rises in 2023 Blue Ridge ranking based on growth of its National Institutes of Health funding to $551 million.

Duke Human Vaccine Institute scientists are targeting a fast-moving protein that could hold the key to developing an effective HIV vaccine.

The Duke Regional Biocontainment Lab (RBL), a vital hub for research of infectious diseases, is gearing up for a new era under the leadership of Herman Staats, PhD, and a significant boost in funding from the National Institutes of Health.  

Researchers at Duke University School of Medicine have unveiled a breakthrough genetic sensor that shines a light on critical changes in our genetic material.   The sensor, developed by a Duke team led by Kate Meyer, PhD, an assistant professor in the Department of Biochemistry, produces a fluorescent glow when it detects m6A, a small but powerful modification in RNA.  

A research team led by the Duke Human Vaccine Institute has activated specific immune cells that induce broadly neutralizing antibodies in a study using monkeys. The next phase of the work will now move to testing in humans.